{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:49:03Z","timestamp":1782899343719,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of large (&amp;gt;2\u00a0cm) type 1 gastric neuroendocrine tumors (gNETs), typically associated with autoimmune gastritis, remains controversial, balancing curative intent against procedural invasiveness. This report aims to demonstrate that, with precise preoperative staging and advanced endoscopic techniques, curative organ-preserving resection is a viable option for selected cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 48-year-old female presented with markedly elevated serum gastrin (3100 pg\/mL) and gastroscopy revealed two dominant lesions: a 2.5\u00a0cm lesion at the esophagogastric junction and a 1.8\u00a0cm lesion on the gastric body, the background gastric mucosa showed atrophy with scattered nodules. Comprehensive staging with endoscopic ultrasound and 68Ga-DOTATATE PET\/CT, incorporating histopathology from biopsy confirming a type I gNET, G2 grade, established a localized, non-metastatic disease. After multidisciplinary discussion, the patient opted for endoscopic resection. The junctional tumor was completely removed en bloc using a tailored technique of endoscopic submucosal dissection with deliberate muscularis propria exposure (ESD-MPE), while the gastric body lesion was resected via conventional ESD. Final pathology confirmed both as pT1b, G2 NETs with all margins negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For carefully selected, larger type I gNETs without metastasis, ESD\u2212MPE represents an effective minimally invasive treatment option. This technique reflects the trend toward deeper and more precise endoscopic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1872571","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:17:16Z","timestamp":1782897436000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Endoscopic submucosal dissection with deliberate muscularis propria exposure for curative resection of a large type 1 gastric neuroendocrine tumor: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Nana","family":"An","sequence":"first","affiliation":[{"name":"Department of Endoscopy, The Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, The Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limian","family":"Er","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, The Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endoscopy, The Fourth Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/287825","article-title":"Current concepts on gastric carcinoid tumors","volume":"2012","author":"Nikou","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/0016-5085(93)90266-f","article-title":"Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study","volume":"104","author":"Rindi","year":"1993","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i30.6817","article-title":"Management of gastric and duodenal neuroendocrine tumors","volume":"22","author":"Sato","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3","volume":"35","author":"Panzuto","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"key":"B7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","article-title":"Neuroendocrine tumors, version 1.2015","volume":"13","author":"Kulke","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"B8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4251\/wjgo.v12.i8.791","article-title":"Gastrointestinal neuroendocrine tumors in 2020","volume":"12","author":"Ahmed","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i35.5376","article-title":"Gastric neuroendocrine neoplasms type 1: a systematic review and meta-analysis","volume":"25","author":"Tsolakis","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000012101","article-title":"Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: a Digestive Endoscopy Society of Tawian (DEST)","volume":"97","author":"Chung","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619890465","article-title":"Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: a systematic review and meta-analysis","volume":"8","author":"Rossi","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16315","DOI":"10.1038\/s41598-025-99791-2","article-title":"A single center retrospective analysis of feasibility of diagnostic endoscopic resection for grade 1 or 2 gastric neuroendocrine tumors","volume":"15","author":"Jang","year":"2025","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1652-0","article-title":"Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids","volume":"18","author":"Saund","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i5.104577","article-title":"Last decade of advances in gastric neuroendocrine tumors: innovations, challenges, and future directions","volume":"16","author":"Christodoulidis","year":"2025","journal-title":"World J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1590\/0102-6720201700020016","article-title":"Gastric neuroendocrine tumor: review and update","volume":"30","author":"Dias","year":"2017","journal-title":"Arq Bras Cir Dig"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2019.11.009","article-title":"Management of other gastric and duodenal neuroendocrine tumors","volume":"29","author":"Laird","year":"2020","journal-title":"Surg Oncol Clin N Am"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-02990-4","article-title":"68Ga-DOTATATE PET\/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis","volume":"46","author":"Jackson","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.64.0987","article-title":"Prospective study of 68Ga-DOTATATE positron emission tomography\/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites","volume":"34","author":"Sadowski","year":"2016","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13645706.2026.2642667","article-title":"Endoscopic intermuscular dissection and endoscopic submucosal dissection for treatment of rectal neuroendocrine tumors: a retrospective cohort study","volume":"35","author":"Han","year":"2026","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10151-025-03237-w","article-title":"Short-term outcomes of endoscopic intermuscular dissection for early rectal cancer with deep submucosal infiltration: a single-center experience from China","volume":"29","author":"Yang","year":"2025","journal-title":"Tech Coloproctol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1872571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:17:17Z","timestamp":1782897437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1872571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":20,"alternative-id":["10.3389\/fonc.2026.1872571"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1872571","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1872571"}}